Sandra Rivas Msc

Sandra Rivas, MSc, RAC, currently serves as Vice President and Head of Regulatory Affairs at SonoThera since March 2025. Additionally, Sandra has been the President of RCG Real Estate Holdings, LLC since 2012, focusing on real estate investing. Prior experience includes senior regulatory roles at Sarepta Therapeutics, where Sandra was Senior Director of Regulatory Affairs for Gene Therapy, and BeiGene, where Sandra served as Director of Regulatory Affairs in Oncology. Expertise in regulatory strategy development and project management is evident from a career that includes positions at Precision For Medicine, Halloran Consulting Group, Ultragenyx Pharmaceutical, Allergan, Arena Pharmaceuticals, and Newport Scientific. Sandra's educational credentials include a Master's in Clinical Science from UC San Diego, a Certificate in Advanced Biosciences from UC Berkeley, and a BS in Biochemistry from California State University-Los Angeles, complemented by executive education from Harvard Business School.